SUMMARY Female patients with a sex chromosome abnormality may be fertile. In patients with a 47,XXX cell line there appears to be an increased risk of a cytogenetically abnormal child but the extent of this risk cannot yet be determined; it is probably lower in the non-mosaic 47,XXX patient than the mosaic 46,XX/47,XXX one. Patients with a 45,X cell line rarely become pregnant, and when they do they appear to have a high risk of an abnormal child or repeated unsuccessful pregnancies; this risk is certainly exaggerated by the method of reporting; when the poor reproductive performance is first identified leading to the recognition of the maternal cytogenetic fault, the reproductive failure rate is naturally high; when the maternal fault is first identified and the reproductive history then established far better results are evident.
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Patients with sex chromosome anomalies usually present in clinical practice as examples of gonadal dysgenesis with primary amenorrhoea, streak gonads, and absolute sterility. There are exceptions, however, notably individuals with a 47,XXX karyotype who are known to be fertile (Barr et al., 1969) and certain patients with a mosaic karyotype or with deletions or isochromosomes who develop a degree of ovarian differentiation compatible with secondary sexual development, menstruation, or rare fertility . The reproductive performance of the 47,XXX group is surprisingly good though a small number of children who are cytogenetically abnormal have been described. The reproductive performance in the latter group is alarming, the outcome being an abortion or an abnormal child in a high percentage of reported cases. A thorough review of the subject seemed appropriate in an attempt to clarify the picture and to determine with greater certainty the risk of an abnormal child or an unsuccessful pregnancy in such patients. 47,XXX and 46,XX/47,XXX patients Barr et al. (1969) , in a comprehensive review of patients with the above karyotypes, reported on 28 women who had had 67 children, 2 abortions, and 2 terminations of pregnancy. Twenty-nine children had been examined cytogenetically and 24 were found to be normal. The 5 women who bore abnormal children were one with a 47,XXX karyotype, and 4 with a 46,XX/47,XXX karyotype (Table 1) (Rosenkranz, 1965a,b; Fujita and Yamamoto, 1967; Williams, 1969) . It is interesting that there were 4 cytoReceived for publication 31 August 1977 genetically abnormal children among the 14 offspring from only 8 patients with a mosaic karyotype and only one cytogenetically abnormal child from the remaining patients whose karyotype was 47,XXX. Since the report of Barr et al., Kadotani et al. (1970) have reported one 47,XXX patient who gave birth to a child with trisomy 21 Down's syndrome; 4 other abnormal children have, however, been reported who were born to mosaic 46,XX/47,XXX patients (Table 2) (Baikie et al., 1972; Geisler et al., 1972; Tsuang et al., 1975; Zizka et al., 1975) .
These data indicate a greater liability to abnormal offspring in mosaic than non-mosaic patients but suggest that patients with either may have an increased risk of bearing an abnormal child. From the information at present available it is not possible to determine how great this risk might be. 47,XXX or mosaic 46,XX/47,XXX women show no characteristic clinical features and many who bear a normal child will undoubtedly escape recognition unless a deliberate search is made for them , while those who bear an abnormal child are by contrast more likely to be recognised and reported. Indeed a careful scrutiny of the cases referred to above in which abnormal children were born to mothers with a 47,XXX cell line shows that in every case the discovery of the abnormality in the child led to the recognition of the abnormal karyotype in the mother, thus exaggerating the apparent risk. All that can be concluded at present, therefore, is that a mosaic Fertility in 47,XXX and 45,Xpatients Nakashima and Robinson, 1971; Grace et al., 1973; Groll and Cooper, 1976; Philip and Sele, 1976) , 7 who were 45,X/46,XX (Kava and Klinger, 1968; Bomers-Marres, 1966; Predescu et al., 1969; Bishun et al., 1969; Mackay et al., 1971; Siegelman, 1972; Lieber and Berger, 1973) , 4 who were 45,X/ 46,XX/47,XXX (Briggs et al., 1963; de Toni et al., 1965; Armendares et al., 1967; Nielsen and Thomsen, 1968; Giraud, 1970; Hsu et al., 1972; Kim et al., 1975) . The outcome of the pregnancy in these patients is set out in Tables 3, 4 , 5, and 6 from which it may be seen that 54 pregnancies have occurred resulting in 16 miscarriages, 1 termination, 12 abnormal children, 3 children who were stillborn without sufficient details to Table 7 . This is an appalling reproductive performance and gives rise to considerable concern. However, if the reports are divided into those in which the abnormal child or the poor reproductive performance led to the recognition of the maternal faults and those in which the mother's abnormality was discovered first and her fertility record then established, a different picture emerges (Table 8 ). It is clear that when the mother is identified first her reproductive performance is far better than the impression given by the review of the patients as a whole. Indeed, as with the group of 47,XXX women, the apparent risk of abnormality is considerably exaggerated by the method of reporting. One paper has not been included in the review and its omission requires comment. Arakaki and Waxman (1970) (Singh and Carr, 1966) ; these are destroyed almost totally by the time of birth or soon afterwards, probably because of the failure of pre-granulosa cells to surround the germ cell and form primary follicles; germ cells not surrounded in this fashion, but left exposed to ovarian stroma, are quickly destroyed (Baker, 1963) . This destruction is to some extent a normal process during intrauterine development and results in a reduction in the number of oocytes from almost 7 000 000 at the fifth month to around 2 000 000 at birth. In the 45,X/46,XX patient, especially one with a high proportion of 46,XX cells, survival until adult life of sufficient germ cells to permit fertility is clearly a possibility. Even in patients without a large preponderance of46,XX cells a favourable distribution of these cells during early embryonic development might have the same effect. In a 45,X patient we may consider that very rarely germ cell survival could occur permitting fertility in exceptional circumstances. The alternative explanation is that the fertile 45,X patients reported are in reality unrecognised mosaics. This seems likely in several cases since only one tissue has been examined cytogenetically; moreover in the case reported by Groll and Cooper (1976) for example, the patient's height (5'1k") strongly suggests the possibility of a normal cell line since it is extremely uncommon for a 45,X patient to be so tall. In other patients, however, such as that reported by Philip and Sele (1976) , mosaicism is far less likely since four tissues were cultured.
